advanced CKD: ACEi/ARB beneficial
A recent systematic review and individual participant-level meta-analysis of clinical trials found that prescribing ACE-inhibitors or ARBs to patients with advanced chronic kidney disease (stage 4 or 5) was beneficial: see ckd ACE ARB good for advanced CKD AnnIntMed2024 in dropbox or doi:10.7326/M23-3236) Details : -- 18 completed randomized controlled trials were found in a literature search from 1946 to 2024 -- 1739 participants were included, mean age 55, 52% female, 15% Black -- median eGFR by creatinine was 23 (IQR 18-27), 32% had eGFR below 20; median albumin-creatinine ratio 1215mg/g (range 527-2463 mg/g) but 84% had “severe albuminuria” (which they did not define, >1000mg???) -- mean systolic BP 155 mmHg -- the issue of determining the overall demographics/comorbidities/etc is difficult given the huge differences in the individual studies, including year study done (varies from 1992 to 2007), different meds used (perindopril-ind...